Season Five

What will it take for Britain to turn its research strengths into companies that stay, scale and list at home? Gordon Sanghera takes listeners through Oxford Nanopore's rise and its decision to list in London. Eva Barboni of Enterprise Britain argues for shorter non-competes to free up talent, and Acorn co-founder Hermann Hauser asks how Europe can fund its next generation of global companies. Conversations with the Weatherall Institute of Molecular Medicine, Immunocore and Genomics follow. The timing matters. UK university spinouts raised £1.3bn of venture capital in 2025, down from £2.2bn in 2024, according to Dealroom's Spotlight on Spinouts report. The ideas are here. Season Five asks what it will take to build on them, starting 29 September. **Susannah de Jager:** Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya and HSBC Innovation Banking. Produced and Edited by Story Ninety-Four in Oxford.